Skip navigation
Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings

Healthcare Reform, Public Perception Mean Greater Scrutiny of Pharma Meetings

How legislative healthcare reform efforts will affect pharmaceutical meetings.

The uncertain future of the country’s healthcare system has direct implications for biopharmaceutical and medical device companies, and in turn will affect the way these companies approach medical meetings and healthcare provider education, said Kim Slocum during a keynote address at the Sixth Annual Pharmaceutical Meeting Management Forum. Organized by Medical Meetings and the Center for Business Intelligence, the forum was held March 14–16 in Philadelphia.

Register to view the full article

Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.

Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish